Alerts will be sent to your verified email
Verify Email
TLL
|
Trident Lifeline
|
Medico Remedies
|
Gennex Lab
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Unclassified
|
|||
|
Advertisement Spend as a % of Total Sales
|
0.37 % | n/a | n/a |
|
Financials
|
|||
|
5 yr Average ROE
|
35.94 % | 11.79 % | 7.82 % |
|
5yr average Equity Multiplier
|
1.91 | 2.18 | 1.53 |
|
5yr Average Asset Turnover Ratio
|
0.9 | 1.48 | 0.75 |
|
5yr Avg Net Profit Margin
|
17.11 % | 3.76 % | 7.88 % |
|
Price to Book
|
6.05 | 5.12 | 1.61 |
|
P/E
|
29.6 | 31.68 | 18.66 |
|
5yr Avg Cash Conversion Cycle
|
94.4 Days | 34.15 Days | 43.23 Days |
|
Inventory Days
|
68.55 Days | 52.67 Days | 49.12 Days |
|
Days Receivable
|
104.41 Days | 107.96 Days | 50.53 Days |
|
Days Payable
|
126.58 Days | 136.18 Days | 75.36 Days |
|
5yr Average Interest Coverage Ratio
|
17.94 | 9.64 | 6.21 |
|
5yr Avg ROCE
|
29.15 % | 17.25 % | 11.17 % |
|
5yr Avg Operating Profit Margin
|
16.89 % | 5.84 % | 10.47 % |
|
5 yr average Debt to Equity
|
0.34 | 0.3 | 0.18 |
|
5yr CAGR Net Profit
|
9.93 % | 38.44 % | 43.63 % |
|
5yr Average Return on Assets
|
15.87 % | 5.66 % | 5.16 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
63.04 % | 62.59 % | 19.83 % |
|
Share Pledged by Promoters
|
3.46 % | 0.0 | 21.79 % |
|
Change in Promoter Holding (3 Yrs)
|
-6.53 % | -10.75 % | -2.22 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Trident Lifeline
|
Medico Remedies
|
Gennex Lab
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
|
Segment Break-Up
|
Segment Break-Up
|
Segment Break-Up
|
-
|
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|